Quality Improvement in Time to Treatment of Status Epilepticus
This is a stepped-wedge cluster randomized effectiveness-implementation hybrid study aimed at determining the effect of dissemination of a QI bundle on the time to treatment of SE among hospitalized, non-critically ill children. The primary study endpoint is to decrease the time from the SE diagnosis to treatment with the first dose of a benzodiazepine (BZD) as measured during hospitalization, which will decrease chances of morbidity and mortality.
• SE episode occurs in a male or female child aged between \> 30 days to \< 19 years
• Seizures meeting AT LEAST ONE of the following criteria:
‣ continuous clinically apparent seizure lasting greater than 5 minutes
⁃ continuous clinically apparent seizure of any duration receiving BZD
⁃ repeated seizures without return to neurological baseline within 5 minutes